Search Results 81-90 of 16169 for pharmacogenetics
The complex genetic basis of common human diseases and traits necessitates the development of new statistical methods to address new questions and new data ...
About this study. The purpose of this study is to create a larger database and bio-repository to examine pharmacogenomics in patients with BD type I and ...
... pharmacogenetic testing. Transplant infectious diseases. Dr. Cummins partners with other researchers at Mayo Clinic to improve the diagnosis and treatment ...
... 2007; U.S. Patent No. 7026163 — Sulfotransferase Sequence Variants, 2006; Member — American Medical Informatics Association, Clinical Pharmacogenetics ...
Predicting response to glucocorticoid treatment represents an unmet need. Dr. Sullivan's team plans to bridge that gap by understanding the pharmacogenetic ...
Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol. 2023 May 1; 38 ... Epub 2022 Dec 06. View PubMed; Castrichini M, Luzum JA, Pereira N.
About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...
Laboratory Genetics enhances clinical patient care through genetic disease study, genetic testing advances and emerging related technologies.
The Mayo Clinic Center for Individualized Medicine's Bioinformatics Program processes, analyzes and interprets raw genomic sequencing data.
The purpose of this study is to provide descriptive information on patients with hereditary hemochromatosis, including their predominant symptoms, time to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.